Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares changing hands.
Anthera Pharmaceuticals Trading Down 100.0%
Anthera Pharmaceuticals Company Profile
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Featured Stories
- Five stocks we like better than Anthera Pharmaceuticals
- Investing in Commodities: What Are They? How to Invest in Them
- Workday Stock Price Implosion: An Automatic Buy for AI Investors
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MercadoLibre Is Soaring—Should You Wait for a Better Entry?
- When to Sell a Stock for Profit or Loss
- Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
